seronegative spondarthritides, once confused with rheumatoid arthritis (RA), is now recognised as a discrete entity on clinical, radiological, histological, and serological grounds.' Since specific drugs therapy for these different conditions is likely to be based on a closer understanding of the underlying pathological processes, it is relevant to compare biochemical abnormalities occurring in different variants of polyarthritis.
Biochemical changes in the blood of patients with RA have been extensively investigated.24 Some of these changes have been claimed to be specific for this disease, e.g., low serum histidine.7 Such studies invariably use the criteria of the American Rheumatism Association for the selection of their patients. These criteria include the presence of circulating rheumatoid factor, but it is not mandatory for a diagnosis of RA to be made. Between 23 %8 and 40%9 of a rheumatoid population are 'seronegative', though the recent interest in 'hidden rheumatoid factor' emphasises that even Accepted for publication 30 September 1980 Correspondence variables it is necessary to allow for any dependence on age and sex. Haemoglobin, total serum sulphydryl, and creatinine were much higher (essentially normal) in the AS group, while ESR and platelet count were lower, and hence nearer normal, than in the SNRA group (Table 4) . No other variable showed a significant difference between these 2 groups. In comparing SPRA with SNRA we found the mean values for several variables to be higher in the SPRA group even though they did not achieve a statistically significant identification. Such variables included haptoglobin and fibrinogen, in keeping with other raised acute phase proteins, alkaline phosphatase, and GGTP, indicating a greater degree of hepatic involvement. These results suggest greater systemic involvement in SPRA, though this may be localised to certain organs, since haemoglobin was depressed equally in both groups.
Total serum sulphydryl was the only other variable equally abnormal (low) in both groups (Tables 3 and 5) . A rise in total serum sulphydryl levels in RA is relatively nonspecific.2' This rise may occur by direct interaction of drugs with serum proteins, and hence may be a temporary or false indication of disease improvement, occurring regardless of the presence or absence of rheumatoid factor. However, all the patients in the present study received aspirin alone for 2 weeks prior to bleeding, and hence the group comparisons are valid. The cause of low serum sulphydryl in RA is still not clear, though serum protein conformational abnormalities resulting in increased disulphide linkages constitute a strong possibility. Alternatively the low levels may be caused by circulating immune complexes in both SPRA and SNRA.
Although differences occurred in several biochemical variables between SPRA and SNRA, the clinical severity in the 2 groups, as defined by the 6 clinical assessments, was remarkably uniform (Table 2) , possibly reflecting admission criteria to the study. However, equivalent clinical severity in the 2 groups was accompanied by comparable changes in serum sulphydryl and haemoglobin, while acutephase reactants and liver function tests were higher in the SPRA group. It therefore remains a possibility that acute phase reactants reflect increased systemic activity not reflected by the clinical symptoms, while the low levels of serum sulphydryl and perhaps haemoglobin are a direct consequence of the pathogenetic processes.
SNRA COMPARED WITH AS
In the case of AS the high incidence of raised acutephase reactants was essentially the same as for the RA groups, with the exception of ESR, which was raised in only 55 % of cases (Table 5 ). Thus a third of the AS patients had raised plasma viscosity, CRP, and haptoglobin with normal ESR. Even when allowance is made for the age and sex dependence of the ESR in a normal population22 there appears to be a clear difference between ESR and other acute-phase reactants in AS. Since the patients were selected for disease activity, it may be that CRP or plasma viscosity are both preferrable to ESR as indices of disease activity.
Anaemia was far less frequent for AS than RA (Tables 4 and 5 ), but haemoglobin levels are sexdependent, the normal range for males being higher than that for females.22 Low total serum sulphydryl was also less frequent in AS and showed a significant difference when compared with that of RA. Age and sex dependence has been shown in one study on patients with RA3, but this is most likely linked with disease severity and duration. These differences in haemoglobin and total serum sulphydryl between AS and RA probably reflect underlying differences in disease pathogenesis. In addition the differences in serum sulphydryl levels lend support to the idea that their low levels in RA may be related to immune complexes. Furthermore the higher haemoglobin levels in the AS group may contribute towards the low ESR, and a high correlation has been demonstrated between these 2 variables in normal subjects22 and in RA and AS patients. 23 Our biochemical findings support the concept of SNRA, SPRA, and AS as discrete disease entities with their own individual biochemical profiles provided the disease is active. At the same time there are some similarities. Where a variable becomes abnormal in a disease, the trend to abnormality is always found in the same direction, whatever the disease. While SCAT by definition remains the best discriminator between SPRA and SNRA, IgA, IgM acute-phase reactants, and serum histidine may also have a role in confirming seropositivity. Serum sulphydryl and haemoglobin were the best discriminators between AS and RA, and the behaviour of these in relation to histidine and the ESR deserves further study, particularly in other seronegative spondarthritides. This may lead to the formulation of 'biochemical diagnostic criteria' that might complement the existing guidelines suggested for RA by the American Rheumatism Association. 
